Severe gastrointestinal bleeding in patients with locally advanced head and neck squamous cell carcinoma treated by concurrent radiotherapy and Cetuximab

被引:0
|
作者
Naoya Murakami
Seiichi Yoshimoto
Fumihiko Matsumoto
Takao Ueno
Yoshinori Ito
Satoru Watanabe
Kazuma Kobayashi
Ken Harada
Mayuka Kitaguchi
Shuhei Sekii
Kana Takahashi
Kotaro Yoshio
Koji Inaba
Madoka Morota
Minako Sumi
Yutaka Saito
Jun Itami
机构
[1] National Cancer Center Hospital,Department of Radiation Oncology
[2] National Cancer Center Hospital,Department of Head and Neck Surgery
[3] National Cancer Center Hospital,Department of Oral Health and Diagnostic Sciences
[4] National Cancer Center Hospital,Endoscopy Division
关键词
EGFR inhibitor; Cetuximab; Radiation therapy; Gastrointestinal bleeding; Adverse effect; Head and neck squamous cell carcinoma;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:177 / 184
页数:7
相关论文
共 50 条
  • [1] Severe gastrointestinal bleeding in patients with locally advanced head and neck squamous cell carcinoma treated by concurrent radiotherapy and Cetuximab
    Murakami, Naoya
    Yoshimoto, Seiichi
    Matsumoto, Fumihiko
    Ueno, Takao
    Ito, Yoshinori
    Watanabe, Satoru
    Kobayashi, Kazuma
    Harada, Ken
    Kitaguchi, Mayuka
    Sekii, Shuhei
    Takahashi, Kana
    Yoshio, Kotaro
    Inaba, Koji
    Morota, Madoka
    Sumi, Minako
    Saito, Yutaka
    Itami, Jun
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (01) : 177 - 184
  • [2] SEVERE GASTROINTESTINAL BLEEDING IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA TREATED BY CONCURRENT RADIOTHERAPY AND CETUXIMAB
    Murakami, Naoya
    Yoshimoto, Seiichi
    Matsumoto, Fumihiko
    Ueno, Takao
    Ito, Yoshinori
    Kobayashi, Kazuma
    Harada, Ken
    Kitaguchi, Mayuka
    Sekiii, Shuhei
    Takahashi, Kana
    Yoshio, Kotaro
    Inaba, Koji
    Morota, Madoka
    Sumi, Minako
    Saito, Yutaka
    Itami, Jun
    ANTICANCER RESEARCH, 2014, 34 (10) : 6075 - 6075
  • [3] Acute toxicity in 14 patients with locally advanced head and neck squamous cell carcinoma treated with concurrent cetuximab and radiotherapy
    Valeriani, M.
    Muni, R.
    Osti, M. F.
    De Sanctis, V.
    Minniti, G.
    Ardito, F.
    Enrici, R. Maurizi
    RADIOLOGIA MEDICA, 2012, 117 (01): : 125 - 132
  • [4] Concurrent cisplatin or cetuximab with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma A meta-analysis
    Tang, Wen-Hua
    Sun, Wei
    Long, Guo-Xian
    MEDICINE, 2020, 99 (36)
  • [5] Mono centric experience of concurrent Radiotherapy and Cetuximab in the treatment of locally advanced squamous cell carcinoma of the head and neck
    Roman, J.
    Miglierini, P.
    Le Fur, E.
    Miranda, O.
    Pradier, O.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 : 100 - 100
  • [6] Concurrent radiotherapy and chemotherapy for locally advanced squamous cell carcinoma of the head and neck
    Ali, Elsayed M.
    Abdelraheem, Ahmad G.
    HEAD & NECK ONCOLOGY, 2011, 3
  • [7] Cetuximab plus radiotherapy for the treatment of locally advanced squamous cell carcinoma of the head and neck
    Griffin, S.
    Walker, S.
    Sculpher, M.
    White, S.
    Erhorn, S.
    Brent, S.
    Dyker, A.
    Ferrie, L.
    Gilfillan, C.
    Horsley, W.
    Macfarlane, K.
    Thomas, S.
    HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 49 - 54
  • [8] Cisplatin Versus Cetuximab With Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
    Husain, Zain A.
    Burtness, Barbara A.
    Decker, Roy H.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (05) : 396 - +
  • [9] Management of dermatitis in patients with locally advanced squamous cell carcinoma of the head and neck receiving cetuximab and radiotherapy
    Cabezon Gutierrez, Luis
    Khosravi-Shahi, Parham
    Escobar Alvarez, Yolanda
    ORAL ONCOLOGY, 2012, 48 (04) : 293 - 297
  • [10] Concurrent Radiotherapy With Cetuximab or Platinum-based Chemotherapy for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
    Lu, Sharon M.
    Lien, Winston W.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (01): : 95 - 99